AQP4 and brain edema: To test the hypothesis that AQP4 is a potential drug target for TBI via aggravating the severity of brain edema, we intravenously injected neutralized-AQP4 antibody in rats within 30–60 min after TBI and investigated the acute outcome of brain edema formation.